Skip to main content
Matthew Sinclair, MD, Nephrology, Durham, NC

MatthewSinclairMD

Nephrology Durham, NC

Physician

Dr. Sinclair is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sinclair's full profile

Already have an account?

  • Office

    300 W Morgan St
    Durham, NC 27701
    Phone+1 919-668-0113

Education & Training

  • Duke University School of Medicine
    Duke University School of MedicineMHS, Clinical Research, 2019 - 2022
  • Duke University Hospital
    Duke University HospitalFellowship, Nephrology, 2018 - 2021
  • Zucker School of Medicine at Hofstra/Northwell
    Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2014 - 2017
  • Howard University College of Medicine
    Howard University College of MedicineClass of 2014

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2018 - 2025
  • NY State Medical License
    NY State Medical License 2016 - 2019
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Nephrology

Publications & Presentations

PubMed

Press Mentions

  • Automated Quantification of Myocardial Tissue Characteristics from Native T1 Mapping Using Neural Networks with Uncertainty-Based Quality-Control
    Automated Quantification of Myocardial Tissue Characteristics from Native T1 Mapping Using Neural Networks with Uncertainty-Based Quality-ControlAugust 20th, 2020
  • Why Can’t We Flozinate?: Reflections on Our Inability to Optimally Prescribe Sodium Glucose Cotransporter-2 Inhibitors (SGLT2i’s) to the Patients That Need Them Most
    Why Can’t We Flozinate?: Reflections on Our Inability to Optimally Prescribe Sodium Glucose Cotransporter-2 Inhibitors (SGLT2i’s) to the Patients That Need Them MostSeptember 21st, 2023